• SENSEX 71,909.70
    -570.59 (--0.79%)
  • BANKNIFTY 54,450.75
    -182.30 (--0.33%)
  • ICICI Bank
    1,305.50 1,187.55(%)
  • NSE
    1,735.10 1,735.10(%)
  • Moneyview
    62.00 62.00(%)
  • HDFC Bank
    721.45 1,020.35(%)
  • Reliance Industries
    1,161.00 1,161.00(%)
  • Bharti Airtel
    1,726.05 1,726.05(%)
  • Kotak Mah. Bank
    435.55 452.98(%)
  • Infosys
    1,035.00 1,727.85(%)
  • Eternal
    309.80 212.55(%)
  • Molbio Diagnosti
    1,569.80 1,686.50(%)
  • SBI
    945.55 857.30(%)
  • Hero Motors
    167.80 167.80(%)
  • PB Fintech.
    965.00 965.00(%)
  • M & M
    2,812.60 2,812.60(%)
  • T R I L
    298.70 501.25(%)
  • Cupid
    314.40 314.40(%)
  • Ather Energy
    1,372.85 566.00(%)
  • Bank of Baroda
    234.00 325.55(%)
  • A-One Steels
    469.45 469.45(%)
  • Maruti Suzuki
    11,304.30 11,304.30(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Parenterals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 95970.0
  • ISIN : INE0H9F01037
523.65 -6 (-1.07%)
  • As on 01 Oct 2026 (EOD)

  • Today’s Low

    515.00

  • Today’s High

    533.35

  • Open

    529.35

  • Perv Close

    529.30

  • 52W Low

    400.00

  • 52W High

    706.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    2,313.45

  • Div & Yield %

    0.00

  • Book Value(₹)

    110.23

  • Debt-Equity Ratio

    -1.07

  • AGM Date

    01-Oct-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.77

  • Mar.Cap (₹Cr.)

    2,313.45

  • RONW (%)

    15.88

  • ROCE (%)

    16.13

Score Board

  • Equity (₹ in Cr.)

    22.09

  • BV (₹)

    110.20

  • Sales( ₹ in Cr.)

    165.95

  • NP (in Cr.)

    16.78

  • NP Var(%)

    63.0

  • Div%

    0.0

  • CPS (₹)

    5.10

  • EPS (₹)

    3.80

  • Traded Value (₹ in Lakhs)

    2,310.13

  • 52 Week High

    706.00

  • 52 Week Low

    400.00

  • Price BSE

    523.0

  • Price NSE

    524.00

  • Market Capital( in Cr.)

    2,310.13

  • P/C Ratio

    102.40

  • P/E Ratio

    137.70

  • Price Vs.BV

    3.80

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar
INCOME :            
Sales Turnover 165.95 126.58 113.89 96.80 - -
Excise Duty 0.00 0.00 0.00 0.00 - -
Net Sales 165.95 126.58 113.89 96.80 - -
Other Income 4.84 0.32 1.09 0.21 - -
Stock Adjustments 1.69 0.16 0.57 6.75 - -
Total Income 172.48 127.06 115.55 103.76 - -
EXPENDITURE :            
Raw Materials 105.89 73.58 71.89 64.59 - -
Power and Fuel Cost 2.61 2.15 2.35 1.52 - -
Employee Cost 14.30 10.92 10.31 8.92 - -
Other Manufacturing Expenses 0.94 0.71 1.68 1.63 - -
Selling and Administration Expenses 9.76 5.98 4.15 3.64 - -
Miscellaneous Expenses 1.96 4.22 2.60 5.58 - -
Employee Benefit Expenses 14.30 10.92 10.31 8.92 - -
Less: Preoperative Expenditure -3.70 -2.32 0.00 0.00 - -
Total Expenses 139.16 99.89 92.99 85.87 - -
Operating Profit 33.32 27.17 22.55 17.87 - -
Interest 8.77 7.31 6.17 4.81 - -
Gross Profit 24.55 19.86 16.38 13.06 - -
Depreciation 5.78 5.49 6.18 5.79 - -
Profit Before Tax 18.77 14.37 10.20 7.27 - -
Current Tax 2.97 4.09 3.22 2.70 - -
Fringe Benefit tax 0.00 0.00 0.00 0.00 - -
Deferred Tax -0.98 0.00 -0.18 -0.03 - -
Reported Net Profit 16.78 10.28 7.16 4.60 - -
Extraordinary Items 0.00 0.00 -0.02 0.05 - -
Adjusted Net Profit 16.78 10.28 7.18 4.55 - -
Adjustment below Net Profit 0.08 2.08 0.00 0.00 - -
P & L Balance brought forward 32.70 20.34 13.25 8.65 - -
Statutory Appropriations 0.00 0.00 0.00 0.00 - -
Appropriations 0.00 0.00 0.00 0.00 - -
P & L Balance carried down 49.56 32.70 20.42 13.25 - -
Dividend 0.00 0.00 0.00 0.00 - -
Preference Dividend 0.00 0.00 0.00 0.00 - -
Equity Dividend (%) 0.00 0.00 0.00 0.00 - -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 - -
Earnings Per Share-Unit Curr 3.80 3.86 5.41 6.43 - -
Earnings Per Share(Adj)-Unit Curr - - - - - -
Book Value 110.23 34.27 58.94 44.02 - -
Book Value(Adj)-Unit Curr - - - - - -

Shareholding Pattern

  • Promoter Group

    51.16%

  • Public Share Holding

    48.84%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 22,600,001 51.16 22,600,001 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 22,600,001 51.16 22,600,001 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,780,953 4.03 1,780,953 7
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,040,328 2.35 1,040,328 1
Mutual Funds / UTI 433,364 0.98 433,364 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 2,294,104 5.19 2,294,104 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 5,548,749 12.56 5,548,749 12
2] Non Institution
Bodies Corporate 3,206,562 7.26 3,206,562 58
Clearing Members 299,924 0.68 299,924 7
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 247,811 0.56 247,811 173
Foreign Non Institution Other 937,500 2.12 937,500 1
Hindu Undivided Families 146,454 0.33 146,454 172
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 8,193,789 18.55 8,193,789 36
Individuals holding nominal share capital up to Rs. 1 lakh 2,998,141 6.79 2,998,141 8,848
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,030,481 36.29 16,030,481 9,296
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 44,179,231 100.00 44,179,231 9,312

Company Background

Sai Parenterals LtdPharmaceuticals - Indian - Formulations

  • Sai Parenterals Ltd
  • BSE Code : 95970.0
  • ISIN : INE0H9F01037

  • Incorporation Year

    2001

  • Registered Office

    No.39 5th Flr Lavanya Arcade-
    Jayabheri Enclave Gachibowli, Ranga Reddy,
    Telangana-500032

  • Telephone

    +91 79979 91301

  • FAX

  • Chairman

    ANIL KUMAR KARUSALA

  • Managing Director

    ANIL KUMAR KARUSALA

  • Company Secretary

    Shivali Aggarwal

  • Auditor

    R Kabra & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    Bigshare Services Pvt Ltd
    Office No S6-2,
    Pinnacle Busine.Park,Mahakali Caves Road
    Mumbai - Mumbai - 400093

Sai Parenterals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Parenteral's 522.90 167.09 162.25 0.00 7.01
Abbott India 26,832.10 7,217.19 6,929.05 35.31 43.78
Astrazeneca Phar 6,030.45 2,304.07 2,275.58 88.88 27.86
Glaxosmi. Pharma 2,774.50 3,932.76 3,790.20 44.32 58.17
Novartis India 1,967.85 393.10 354.33 49.69 15.94
Cipla 1,346.85 20,102.60 18,979.95 35.40 13.88
Bliss GVS Pharma 684.20 773.53 729.81 63.59 12.51
Fermenta Biotec. 551.35 474.15 450.25 25.74 18.77
Amrutanjan Healt 513.80 520.13 502.55 27.52 24.16
Guj. Themis Bio. 382.35 168.25 165.82 102.23 18.05
Ambalal Sarabhai 37.92 19.52 3.94 70.22 6.77